management of alk-positive, nsclc
Published 9 years ago • 267 plays • Length 6:23Download video MP4
Download video MP3
Similar videos
-
6:22
targeted tkis used for treatment of alk-positive nsclc
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
8:24
second-line treatment for alk-positive nsclc
-
11:14
holistic management of patients with alk-positive nsclc
-
1:17
dr. xia on the frontline treatment landscape of alk-positive nsclc
-
8:02
updates informing the management of alk-rearranged mnsclc
-
8:24
second-line treatment for alk-positive nsclc
-
4:08
treatment of alk-driven refractory nsclc
-
8:57
optimal approaches for resectable alk-driven nsclc | biomarker-guided therapy in nsclc and beyond...
-
42:31
alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
-
2:18
【一表看清自費癌症藥物資助計劃詳情】
-
0:58
progress in the treatment of alk-positive non-small cell lung cancer
-
1:07
dr. massarelli on first-line alk nsclc treatment
-
2:29:54
lung cancer | striving for consensus on the management of alk-positive lung cancer
-
2:10
molecularly-guided treatment of advanced nsclc: alk inhibitor sequencing
-
4:31
alk-positive nsclc: alex trial
-
3:04
management of frontline alk nsclc: brigatinib vs. alectinib
-
1:22:33
management of alk rearranged nsclc.
-
4:23
alecensa: targeted therapy for alk-positive lung cancer
-
1:08:32
management of alk rearranged nsclc in first line.
-
13:28
debate: alk positive nsclc - front line therapy - crizotinib
-
1:52
dr. drilon on the utility of brigatinib in alk nsclc